Psoriasis Therapeutics in Asia-Pacific Market Expected to Grow at a CAGR of 8.4% by 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth
Research, the leading business intelligence provider, has released its latest research, ""Systemic Psoriasis Therapeutics in Asia-Pacific Markets to 2021 - Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth"", which provides insights into psoriasis therapeutics in the Asia-Pacific (APAC) market. For the purposes of this report, APAC refers to the market in China, India, Japan, and Australia only. The report estimates the market size for 2014, along with forecasts until 2021. It also covers disease epidemiology, treatment algorithms,...
View full press release